Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Sheppard

Showing results (351-360 of 397) with videos related to

Pageof 40
Sort By:
Cornea|July 26, 2013
Long-term Supplementation With n-6 and n-3 PUFAs Improves Moderate-to-Severe Keratoconjunctivitis Sicca: A Randomized Double-Blind Clinical TrialJohn D Sheppard, Ruhi Singh, Andrew J McClellan, et al.
Diabetologia|September 25, 2012
Implementation of the automated Leicester Practice Risk Score in two diabetes prevention trials provides a high yield of people with abnormal glucose toleranceL J Gray, K Khunti, C Edwardson, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 23, 2000
DNA fingerprinting of a national sample of Mycobacterium tuberculosis isolates, Botswana, 1995-1996S Lockman, J D Sheppard, M Mwasekaga, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|February 2, 2023
Does Dry Eye Disease Severity Impact Efficacy of Varenicline Solution Nasal Spray on Sign and Symptom Treatment Outcomes?John D Sheppard, Leslie E O'Dell, Paul M Karpecki, et al.
Chemical Science|February 19, 2025
Borate-catalysed direct amidation reactions of coordinating substratesRichard J Procter, Carla Alamillo-Ferrer, Usman Shabbir, et al.
Molecular Pharmacology|October 29, 2005
Reversing hypoxic cell chemoresistance in vitro using genetic and small molecule approaches targeting hypoxia inducible factor-1Louisa M Brown, Rachel L Cowen, Camille Debray, et al.
Cornea|September 4, 2021
A Water-free 0.1% Cyclosporine A Solution for Treatment of Dry Eye Disease: Results of the Randomized Phase 2B/3 ESSENCE StudyJohn D Sheppard, David L Wirta, Eugene McLaurin, et al.
Science (New York, N.Y.)|December 18, 1998
Requirement for IL-13 independently of IL-4 in experimental asthmaG Grünig, M Warnock, A E Wakil, et al.
RSC Advances|April 3, 2023
Mechanoenzymatic reactions for the hydrolysis of PETEsther Ambrose-Dempster, Leona Leipold, Dragana Dobrijevic, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|May 8, 2012
IQGAP1 is necessary for pulmonary vascular barrier protection in murine acute lung injury and pneumoniaM Bhattacharya, G Su, X Su, et al.
Pageof 40

Showing results (351-360 of 397) with videos related to

Sort By:
Pageof 40
Cornea|July 26, 2013
Long-term Supplementation With n-6 and n-3 PUFAs Improves Moderate-to-Severe Keratoconjunctivitis Sicca: A Randomized Double-Blind Clinical TrialJohn D Sheppard, Ruhi Singh, Andrew J McClellan, et al.
Diabetologia|September 25, 2012
Implementation of the automated Leicester Practice Risk Score in two diabetes prevention trials provides a high yield of people with abnormal glucose toleranceL J Gray, K Khunti, C Edwardson, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 23, 2000
DNA fingerprinting of a national sample of Mycobacterium tuberculosis isolates, Botswana, 1995-1996S Lockman, J D Sheppard, M Mwasekaga, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|February 2, 2023
Does Dry Eye Disease Severity Impact Efficacy of Varenicline Solution Nasal Spray on Sign and Symptom Treatment Outcomes?John D Sheppard, Leslie E O'Dell, Paul M Karpecki, et al.
Chemical Science|February 19, 2025
Borate-catalysed direct amidation reactions of coordinating substratesRichard J Procter, Carla Alamillo-Ferrer, Usman Shabbir, et al.
Molecular Pharmacology|October 29, 2005
Reversing hypoxic cell chemoresistance in vitro using genetic and small molecule approaches targeting hypoxia inducible factor-1Louisa M Brown, Rachel L Cowen, Camille Debray, et al.
Cornea|September 4, 2021
A Water-free 0.1% Cyclosporine A Solution for Treatment of Dry Eye Disease: Results of the Randomized Phase 2B/3 ESSENCE StudyJohn D Sheppard, David L Wirta, Eugene McLaurin, et al.
Science (New York, N.Y.)|December 18, 1998
Requirement for IL-13 independently of IL-4 in experimental asthmaG Grünig, M Warnock, A E Wakil, et al.
RSC Advances|April 3, 2023
Mechanoenzymatic reactions for the hydrolysis of PETEsther Ambrose-Dempster, Leona Leipold, Dragana Dobrijevic, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|May 8, 2012
IQGAP1 is necessary for pulmonary vascular barrier protection in murine acute lung injury and pneumoniaM Bhattacharya, G Su, X Su, et al.
Pageof 40